Creo Medical’s CEO Craig Gulliford says elective surgery has bounced back from the pandemic in all parts of the world, helping revenues jump ahead in 2021.
The business today also announced a partnership with NASDAQ-listed Intuitive Surgical (NASDAQ:ISRG) to dovetail its surgical endoscopy range with the US firm’s robotic technology.
US acquisitions, more partnerships and additional technologies are all on the agenda he says.
“It’s all about the patients,” he adds.